 Immunoglobulin G
"Immunoglobulin G" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
| Descriptor ID |
D007074
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.393 D12.776.124.790.651.114.619.393 D12.776.377.715.548.114.619.393
|
| Concept/Terms |
IgG(T)- IgG(T)
- Immunoglobulin GT
- GT, Immunoglobulin
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin G".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin G".
This graph shows the total number of publications written about "Immunoglobulin G" by people in this website by year, and whether "Immunoglobulin G" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 0 | 2 | 2 | | 1982 | 0 | 3 | 3 | | 1983 | 0 | 1 | 1 | | 1984 | 1 | 1 | 2 | | 1985 | 1 | 3 | 4 | | 1986 | 3 | 1 | 4 | | 1987 | 1 | 3 | 4 | | 1988 | 1 | 6 | 7 | | 1989 | 1 | 4 | 5 | | 1990 | 2 | 2 | 4 | | 1991 | 3 | 7 | 10 | | 1992 | 3 | 6 | 9 | | 1993 | 3 | 1 | 4 | | 1994 | 2 | 5 | 7 | | 1995 | 4 | 4 | 8 | | 1996 | 4 | 4 | 8 | | 1997 | 2 | 4 | 6 | | 1998 | 3 | 5 | 8 | | 1999 | 1 | 9 | 10 | | 2000 | 3 | 10 | 13 | | 2001 | 6 | 10 | 16 | | 2002 | 1 | 9 | 10 | | 2003 | 7 | 7 | 14 | | 2004 | 5 | 11 | 16 | | 2005 | 6 | 8 | 14 | | 2006 | 6 | 12 | 18 | | 2007 | 3 | 14 | 17 | | 2008 | 6 | 12 | 18 | | 2009 | 8 | 19 | 27 | | 2010 | 10 | 9 | 19 | | 2011 | 11 | 15 | 26 | | 2012 | 12 | 15 | 27 | | 2013 | 13 | 13 | 26 | | 2014 | 12 | 8 | 20 | | 2015 | 12 | 12 | 24 | | 2016 | 8 | 11 | 19 | | 2017 | 7 | 9 | 16 | | 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoglobulin G" by people in Profiles.
-
Mueller SW, Baumgartner LJ, MacLaren R, Neumann R, Wiktor AJ, Kiser TH, Lindberg G, Cava L, Fish DN, Janoff EN. Divergent humoral responses to 23-valent pneumococcal polysaccharide vaccine in critically-ill burn and neurosurgical patients. PLoS One. 2018; 13(5):e0197037.
-
McGuire EP, Fong Y, Toote C, Cunningham CK, McFarland EJ, Borkowsky W, Barnett S, Itell HL, Kumar A, Gray G, McElrath MJ, Tomaras GD, Permar SR, Fouda GG. HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine. J Virol. 2018 01 01; 92(1).
-
Falloon J, Yu J, Esser MT, Villafana T, Yu L, Dubovsky F, Takas T, Levin MJ, Falsey AR. An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults. J Infect Dis. 2017 Dec 12; 216(11):1362-1370.
-
Beseler C, Vollmer T, Graner M, Yu X. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution. PLoS One. 2017; 12(10):e0186842.
-
Sokoya M, Ramakrishnan VR, Frank DN, Rahkola J, Getz A, Kingdom TT, Kofonow JM, Nguyen Q, Janoff EN. Expression of immunoglobulin D is increased in chronic rhinosinusitis. Ann Allergy Asthma Immunol. 2017 10; 119(4):317-323.e1.
-
Frost HM, Schotthoefer AM, Thomm AM, Dupuis AP, Kehl SC, Kramer LD, Fritsche TR, Harrington YA, Knox KK. Serologic Evidence of Powassan Virus Infection in Patients with Suspected Lyme Disease1. Emerg Infect Dis. 2017 08; 23(8):1384-1388.
-
Shimizu F, Schaller KL, Owens GP, Cotleur AC, Kellner D, Takeshita Y, Obermeier B, Kryzer TJ, Sano Y, Kanda T, Lennon VA, Ransohoff RM, Bennett JL. Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica. Sci Transl Med. 2017 07 05; 9(397).
-
Lieu CH, Hidalgo M, Berlin JD, Ko AH, Cervantes A, LoRusso P, Gerber DE, Eder JP, Eckhardt SG, Kapp AV, Tsuhako A, McCall B, Pirzkall A, Uyei A, Tabernero J. A Phase Ib Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Cobimetinib and Duligotuzumab in Patients with Previously Treated Locally Advanced or Metastatic Cancers with Mutant KRAS. Oncologist. 2017 09; 22(9):1024-e89.
-
Ocean AJ, Starodub AN, Bardia A, Vahdat LT, Isakoff SJ, Guarino M, Messersmith WA, Picozzi VJ, Mayer IA, Wegener WA, Maliakal P, Govindan SV, Sharkey RM, Goldenberg DM. Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics. Cancer. 2017 Oct 01; 123(19):3843-3854.
-
Alberga D, Trisciuzzi D, Lattanzi G, Bennett JL, Verkman AS, Mangiatordi GF, Nicolotti O. Comparative molecular dynamics study of neuromyelitis optica-immunoglobulin G binding to aquaporin-4 extracellular domains. Biochim Biophys Acta. 2017 08; 1859(8):1326-1334.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|